MedEquity Capital has acquired LiceGuard. Financial terms were not announced. Needham, Mass.-based LiceGuard markets branded products that eliminate juvenile head lice. Murphy Business & Financial Corp. advised LiceGuard.
Murphy Business & Financial Corporation – Boston Metro announced today that it has successfully advised Needham, Mass.-based LiceGuard through a strategic transaction in which Wellesley Hills, Mass.-based MedEquity Capital made a growth investment in the business.
The mutually beneficial transaction positions LiceGuard — a company that markets a safe and differentiated line of branded products for eliminating juvenile head lice — to grab a larger share of the growing $450 million global head lice treatment sector.
To ensure a thorough capital raise process, LiceGuard engaged Murphy Business & Financial Corporation – Boston Metro to advise in the negotiations. Kevin Dougherty, managing director of Murphy Business – Boston Metro, closely counseled LiceGuard from start to finish.
“We couldn’t be more thrilled about the outcome of this deal,” said Dougherty. “It’s safe to say we looked at this from every angle to make certain that both parties walk away feeling good about LiceGuard’s future. This is a fantastic example of the kind of collaboration that’s occurring in the Boston market between top-tier organizations — we’re glad we could bring this to fruition.
Founder Rami Blum echoed, “We are energized by our partnership with MedEquity and look forward to growing LiceGuard in smart and sustainable ways together.”
Murphy Business & Financial Corporation – Boston Metro is the local office for Clearwater, Fla.-based Murphy Business & Financial Corporation, a full-service business advisory firm, which facilitates business sales, purchases, consulting, valuations, mergers and acquisitions.